
Digital health startups received $57 billion in 2021
It represents a 79% increase over the previous year, CB Insights reports. The COVID-19 pandemic is fueling the appetite for digital health technologies.
Digital health startup companies pulled in record-shattering money from investors in 2021, and analysts expect the interest to continue.
In 2021, digital health startups received $57.2 billion worldwide, according to a report from
The CB Insights “State of Digital Health” report offers perspective on the huge appetite of investors. The firm said the COVID-19 pandemic is driving the demand for more digital health solutions.
Here are some highlights from the report.
Domestic dominance: The U.S. looms as the world leader in the digital health market. American companies pulled in a record $37.9 billion in 2021, a sum surpassing the entire global market in 2020. American companies received $10.8 billion in the fourth quarter of 2021. That’s more than Asia, the world’s second largest market, received in the entire year ($10.7 billion).
More unicorns: Worldwide, there are 85 private startups valued at more than $1 billion, earning the “unicorn” designation. There were 57 unicorns in 2020, so that’s a 49% increase.
Mental health: Startups focusing on mental health received $5.5 billion in 2021, up from $2.3 billion the previous year, or a 139% increase. Investors generally have shown an appetite to put more money in behavioral health in general, and some of that is going to digital health companies.
Record mergers: There were 574 mergers and acquisitions involving digital health startups worldwide in 2021, a 44% increase from 2020. CB Insights expects to see the trend continue as bigger companies enter the digital health market.
Some recent deals include
Bigger deals: The median size of digital health deals in 2021 reached $5 million, up from $4 million the previous year. The average size grew to $25 million, a 47% increase compared to 2020.
Digital therapeutics: The market for digital therapeutics, software-based programs to treat medical issues, rose to a record $3.4 billion, according to the report. Funding for digital therapeutics more than doubled, rising from $1.5 billion in 2020, a 127% increase.
Other analysts have projected more deals involving the healthcare industry in 2022.
Earlier this week, KPMG released a report showing
While the merger of hospital systems dropped last year, analysts project

















































